Circulating Tumor Cells Industry
Description
Wiseguyreports.Com Adds “Circulating Tumor Cells -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023” To Its Research Database
This report studies the global Circulating Tumor Cells market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Circulating Tumor Cells market by companies, region, type and end-use industry.
Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.
The classification of Circulating Tumor Cells (CTCs) products includes CTC enrichment, CTC detection and CTC analysis, and the revenue proportion of CTC enrichment in 2016 is about 43.74%.
North America is the largest supplier of CTCs Products, with a revenue market share nearly 53.18% in 2016. Europe is the second largest supplier of CTCs products, enjoying revenue market share nearly 28.01% in 2016.
Growth of the global CTCs market is mainly driven by increasing prevalence of cancer globally. Increasing prevalence of various cancers such as breast cancer, prostate cancer and lung cancer is expected to drive growth of the CTCs test market over the forecast period.
FDA approvals for various non-invasive diagnostic tests to detect cancer are set to define the regulatory landscape for CTCs tests. Companies in the CTCs market space are expected to invest more on test kits and cost containment procedures to provide innovative diagnostic solutions to the oncologists and physicians for detecting metastasis.
In 2017, the global Circulating Tumor Cells market size was 1220 million US$ and it is expected to reach 3560 million US$ by the end of 2025, with a CAGR of 14.3% during 2018-2025.
Request for Sample Report @ https://www.wiseguyreports.com/sample-request/3267428-global-circulating-tumor-cells-market-size-status-and-forecast-2025
This report focuses on the global top players, covered
Menarini-Silicon Biosystems
Qiagen（Adnagen）
Clearbridge Biomedics
Celsee
Fluidigm
ApoCell
Greiner Bio-one GmbH
Advanced Cell Diagnostics
Aviva Biosciences
Fluxion Biosciences
Sysmex Corporation
Epic Sciences
Cynvenio
CytoTrack
Ikonisys
Vortex BioSciences
Gilupi
Biocept
ScreenCell
ANGLE
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Market segment by Type, the product can be split into
CTC Enrichment
CTC Detection
CTC Analysis
Market segment by Application, split into
Breast Cancer
Prostate Cancer
Colorectal Cancer
Other
Leave a Query @ https://www.wiseguyreports.com/enquiry/3267428-global-circulating-tumor-cells-market-size-status-and-forecast-2025
Table of Contents
Global Circulating Tumor Cells Market Size, Status and Forecast 2025
1 Industry Overview of Circulating Tumor Cells
1.1 Circulating Tumor Cells Market Overview
1.1.1 Circulating Tumor Cells Product Scope
1.1.2 Market Status and Outlook
1.2 Global Circulating Tumor Cells Market Size and Analysis by Regions (2013-2018)
1.2.1 United States
1.2.2 Europe
1.2.3 China
1.2.4 Japan
1.2.5 Southeast Asia
1.2.6 India
1.3 Circulating Tumor Cells Market by Type
1.3.1 CTC Enrichment
1.3.2 CTC Detection
1.3.3 CTC Analysis
1.4 Circulating Tumor Cells Market by End Users/Application
1.4.1 Breast Cancer
1.4.2 Prostate Cancer
1.4.3 Colorectal Cancer
1.4.4 Other
….
3 Company (Top Players) Profiles
3.1 Menarini-Silicon Biosystems
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Circulating Tumor Cells Revenue (Million USD) (2013-2018)
3.2 Qiagen（Adnagen）
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Circulating Tumor Cells Revenue (Million USD) (2013-2018)
3.3 Clearbridge Biomedics
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Circulating Tumor Cells Revenue (Million USD) (2013-2018)
3.4 Celsee
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Circulating Tumor Cells Revenue (Million USD) (2013-2018)
3.5 Fluidigm
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Circulating Tumor Cells Revenue (Million USD) (2013-2018)
3.6 ApoCell
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Circulating Tumor Cells Revenue (Million USD) (2013-2018)
3.7 Greiner Bio-one GmbH
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Circulating Tumor Cells Revenue (Million USD) (2013-2018)
3.8 Advanced Cell Diagnostics
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Circulating Tumor Cells Revenue (Million USD) (2013-2018)
3.9 Aviva Biosciences
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Circulating Tumor Cells Revenue (Million USD) (2013-2018)
3.10 Fluxion Biosciences
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Circulating Tumor Cells Revenue (Million USD) (2013-2018)
3.11 Sysmex Corporation
3.12 Epic Sciences
3.13 Cynvenio
3.14 CytoTrack
3.15 Ikonisys
3.16 Vortex BioSciences
3.17 Gilupi
3.18 Biocept
3.19 ScreenCell
3.20 ANGLE
Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=3267428
Continued…
Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us) Ph: +44 208 133 9349 (Uk)
Media Contact
Company Name: Wiseguyreports.com
Contact Person: Norah Trent
Email: Send Email
Phone: +1 646 845 9349, +44 208 133 9349
City: Pune
State: Maharashtra
Country: India
Website: https://www.wiseguyreports.com/sample-request/3267428-global-circulating-tumor-cells-market-size-status-and-forecast-2025